Apyx Medical Corporation

NasdaqGS:APYX Stok Raporu

Piyasa değeri: US$54.4m

Apyx Medical Yönetim

Yönetim kriter kontrolleri 2/4

Apyx Medical CEO'su Charlie Goodwin, Dec2017 tarihinde atandı, in görev süresi 6.92 yıldır. in toplam yıllık tazminatı $ 1.26M olup, şirket hissesi ve opsiyonları dahil olmak üzere 38.2% maaş ve 61.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.24% ine doğrudan sahiptir ve bu hisseler $ 130.05K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 0.9 yıl ve 5.3 yıldır.

Anahtar bilgiler

Charlie Goodwin

İcra Kurulu Başkanı

US$1.3m

Toplam tazminat

CEO maaş yüzdesi38.2%
CEO görev süresi6.9yrs
CEO sahipliği0.2%
Yönetim ortalama görev süresiless than a year
Yönetim Kurulu ortalama görev süresi5.3yrs

Son yönetim güncellemeleri

We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed

Aug 01
We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed

Recent updates

Apyx Medical Corporation (NASDAQ:APYX) Surges 30% Yet Its Low P/S Is No Reason For Excitement

Nov 23
Apyx Medical Corporation (NASDAQ:APYX) Surges 30% Yet Its Low P/S Is No Reason For Excitement

Is There An Opportunity With Apyx Medical Corporation's (NASDAQ:APYX) 41% Undervaluation?

Sep 14
Is There An Opportunity With Apyx Medical Corporation's (NASDAQ:APYX) 41% Undervaluation?

Apyx Medical Corporation (NASDAQ:APYX) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Aug 07
Apyx Medical Corporation (NASDAQ:APYX) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed

Aug 01
We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed

Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?

Jun 19
Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?

Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive

Apr 18
Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive

Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates

Mar 26
Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates

Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)

Feb 16
Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)

Is Apyx Medical (NASDAQ:APYX) A Risky Investment?

Sep 14
Is Apyx Medical (NASDAQ:APYX) A Risky Investment?

Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?

Jun 07
Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?

Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically

Mar 21
Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically

Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation

Dec 14
Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation

We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate

Aug 30
We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate

Apyx Medical GAAP EPS of -$0.16 beats by $0.03, revenue of $10.3M misses by $0.26M

Aug 11

CEO Tazminat Analizi

Charlie Goodwin'un ücretlendirmesi Apyx Medical'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$28m

Jun 30 2024n/an/a

-US$28m

Mar 31 2024n/an/a

-US$23m

Dec 31 2023US$1mUS$483k

-US$19m

Sep 30 2023n/an/a

-US$15m

Jun 30 2023n/an/a

-US$16m

Mar 31 2023n/an/a

-US$21m

Dec 31 2022US$2mUS$483k

-US$23m

Sep 30 2022n/an/a

-US$19m

Jun 30 2022n/an/a

-US$18m

Mar 31 2022n/an/a

-US$16m

Dec 31 2021US$2mUS$450k

-US$15m

Sep 30 2021n/an/a

-US$15m

Jun 30 2021n/an/a

-US$14m

Mar 31 2021n/an/a

-US$15m

Dec 31 2020US$2mUS$450k

-US$12m

Sep 30 2020n/an/a

-US$16m

Jun 30 2020n/an/a

-US$16m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$2mUS$450k

-US$20m

Sep 30 2019n/an/a

-US$18m

Jun 30 2019n/an/a

-US$15m

Mar 31 2019n/an/a

-US$14m

Dec 31 2018US$1mUS$400k

-US$11m

Sep 30 2018n/an/a

-US$10m

Jun 30 2018n/an/a

-US$12m

Mar 31 2018n/an/a

-US$15m

Dec 31 2017US$2mUS$15k

-US$14m

Tazminat ve Piyasa: Charlie 'nin toplam tazminatı ($USD 1.26M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 647.72K ).

Tazminat ve Kazançlar: Charlie 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Charlie Goodwin (58 yo)

6.9yrs

Görev süresi

US$1,261,470

Tazminat

Mr. Charles D. Goodwin II, also known as Charlie, has been Chief Executive Officer and Director of Apyx Medical Corporation (formerly known as Bovie Medical Corporation) since December 15, 2017 and serves...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Charles Goodwin
President6.9yrsUS$1.26m0.24%
$ 130.0k
Matthew Hill
CFO, Treasurer & Secretaryless than a yearUS$445.95k0.021%
$ 11.3k
Moshe Citronowicz
Senior Vice President12.8yrsUS$538.31k1.21%
$ 659.6k
Stavros Vizirgianakis
Executive Chairmanless than a yearVeri yok4.64%
$ 2.5m
Shawn Roman
Chief Operating Officerno dataVeri yokVeri yok

0.9yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim: APYX 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 0.9 yıl), bu da yeni bir ekibin varlığını gösteriyor.


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Charles Goodwin
President6.9yrsUS$1.26m0.24%
$ 130.0k
Stavros Vizirgianakis
Executive Chairmanless than a yearVeri yok4.64%
$ 2.5m
Lawrence Waldman
Lead Independent Director13.7yrsUS$162.56k0.11%
$ 62.0k
Brian Kinney
Member of Medical Advisory Board5.3yrsVeri yokVeri yok
Gregory Konesky
Member of Scientific Advisory Boardno dataUS$9.30kVeri yok
Yuval Carmel
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Minnie Baylor-Henry
Independent Director5.3yrsUS$116.56k0%
$ 0
Dennis Chi
Member of Medical Advisory Board7.8yrsVeri yokVeri yok
Diane Duncan
Member of Medical Advisory Board6.5yrsVeri yokVeri yok
Paul Ruff
Member of Medical Advisory Board5.3yrsVeri yokVeri yok
Richard Gentile
Member of Medical Advisory Board5.3yrsVeri yokVeri yok
Edward Zimmerman
Member of Medical Advisory Board5.3yrsVeri yokVeri yok

5.3yrs

Ortalama Görev Süresi

69yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: APYX 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.3 yıldır).